EE696 Economic and Clinical Burden Associated with Respiratory Syncytial Virus (RSV) and Expected Impact of Universal Immunization with Nirsevimab Among All Infants in Their First Rsv Season Against Standard of Care in Italy
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.961
https://www.valueinhealthjournal.com/article/S1098-3015(23)04091-3/fulltext
Title :
EE696 Economic and Clinical Burden Associated with Respiratory Syncytial Virus (RSV) and Expected Impact of Universal Immunization with Nirsevimab Among All Infants in Their First Rsv Season Against Standard of Care in Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04091-3&doi=10.1016/j.jval.2023.09.961
First page :
Section Title :
Open access? :
No
Section Order :
10451